Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | PGR | P06401 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 5/20 | 0.37 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MAG | P20916 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5270133 | 1.00 | NOD2 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL342953 | 1.00 | NOD2 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| Water SCHEMBL769017 | 0.99 | NOD2 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| Alanine SCHEMBL11120060 | 0.98 | NOD2 (0.56) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL4450131 | 0.94 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL4452390 | 0.94 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL10598564 | 0.94 | MAPK1 (0.57) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL8203776 | 0.94 | NOD2 (0.52) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL8539918 | 0.93 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A | |
| SCHEMBL4446205 | 0.93 | NOD2 (0.55) | NOD2MAPK1ESR1PGRHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111317822-A | Combined preparation containing flavone and immunoregulation peptide, preparation method and application thereof | 中国科学院过程工程研究所 | 2020-06-23 | — | — | CN | claimed |
| WO-2010007250-A1 | D,D-MURAMYL DIPEPTIDES, DERIVED COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF ATHEROMATOUS PLAQUES | UNIVERSITE DE BOURGOGNE (FR) | 2010-01-21 | — | — | WO | claimed |
| EP-0165123-B1 | LIPOPHILE DERIVATIVES OF MURAMYL PEPTIDES HAVING MACROPHAGE-ACTIVATING PROPERTIES, COMPOSITIONS CONTAINING THEM AND PROCESSES FOR OBTAINING THEM | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1990-08-08 | — | — | EP | claimed |
| US-4101649-A | N-ACETYLMURAMYL-ALANYL-ISOGLUTAMINE | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1978-07-18 | — | — | US | claimed |
| CN-111317822-B | Combined preparation containing flavone and immunoregulation peptide, preparation method and application thereof | 中国科学院过程工程研究所 | 2022-03-08 | — | — | CN | disclosed |
| CN-111317822-A | Combined preparation containing flavone and immunoregulation peptide, preparation method and application thereof | 中国科学院过程工程研究所 | 2020-06-23 | — | — | CN | disclosed |
| WO-2010007250-A1 | D,D-MURAMYL DIPEPTIDES, DERIVED COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF ATHEROMATOUS PLAQUES | UNIVERSITE DE BOURGOGNE (FR) | 2010-01-21 | — | — | WO | disclosed |
| WO-2010007250-A1 | D,D-MURAMYL DIPEPTIDES, DERIVED COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF ATHEROMATOUS PLAQUES | UNIVERSITE DE BOURGOGNE (FR) | 2010-01-21 | — | — | WO | disclosed |
| CN-1512890-A | HCG formulation | 开米卡公司 | 2004-07-14 | — | — | CN | disclosed |
| US-20020142046-A1 | Protein particles for therapeutic and diagnostic use | YEN, RICHARD C.K. | 2002-10-03 | — | — | US | disclosed |
| US-6391343-B1 | PARTICLE COMPRISING FIBRINOGEN BOUND ON SURFACE OF ALBUMIN MATRIX, CAPABLE OF CO-AGGREGATION WITH PLATELETS, AND OF AGGREGATION IN SOLUTION CONTAINING SOLUBLE FIBRINOGEN AT CONCENTRATION NOT CAPABLE OF CLOT FORMATION BY ITSELF | HEMOSPHERE, INC. | 2002-05-21 | — | — | US | disclosed |
| EP-0831793-A4 | PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE | HEMOSPHERE INC (US) | 2000-11-15 | — | — | EP | disclosed |
| US-4939122-A | Amplify tumoricidal properties | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1990-07-03 | — | — | US | disclosed |
| EP-0100734-B1 | PROCESS FOR THE SEPARATION OR PURIFICATION OF A SLEEP PROMOTING FACTOR FROM A BIOLOGICAL SOURCE BY IMMUNOLOGICAL REACTION OF THE ANTIGEN-ANTIBODY KIND | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1986-12-17 | — | — | EP | disclosed |
| EP-0165123-A2 | Lipophile derivatives of muramyl peptides having macrophage-activating properties, compositions containing them and processes for obtaining them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1985-12-18 | — | — | EP | disclosed |
| US-4401659-A | ANTI-INFECTIOUS AGENTS | AGENCE NATIONAL DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1983-08-30 | — | — | US | disclosed |
| EP-0013651-B1 | MURAMYL PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1983-06-15 | — | — | EP | disclosed |
| EP-0013651-A1 | Muramyl peptides fixed on peptide polymers and medicaments containing them | ANVAR Agence Nationale de Valorisation de la Recherche (FR) | 1980-07-23 | — | — | EP | disclosed |
| US-4101649-A | N-ACETYLMURAMYL-ALANYL-ISOGLUTAMINE | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1978-07-18 | — | — | US | disclosed |
| US-4101649-A | N-ACETYLMURAMYL-ALANYL-ISOGLUTAMINE | AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE (ANVAR) (FR) | 1978-07-18 | — | — | US | disclosed |